Immuncell-LC
Pre-clinical- Indications
- Hepatocellular carcinoma
Company intelligence / Profile preview
Bifarma Adiluhung
Jakarta, Indonesiabifarma.co.id ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Commercial
01
Overview
Bifarma Adiluhung is Indonesia’s first GMP-certified manufacturer for stem cell and metabolite processing, focusing on clinically proven generics and innovative biopharmaceuticals. The company has conducted toxicity studies and case studies using secretome from umbilical cord mesenchymal stem cells for degenerative diseases, and has a clinical program using allogenic UCMSC for COVID‑19. It serves as the holding/incubator entity for Kalbe Farma’s biopharma division.
- Therapeutic areas
- NeurologyInfectious Diseases
- Modalities
- Cell therapyStem cell therapyBiologic (biopharmaceutical generics)Secretome-based therapy (from umbilical cord mesenchymal stem cells)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Strategic alliances with international partners via parent company Kalbe Farma in cancer drugs, stem cells, biotechnology research
Beyond the preview
Go deeper on Bifarma Adiluhung.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bifarma Adiluhung.